Skip to main content

Table 2 Baseline characteristics according to categorization of asthma diagnosis n = 338

From: Asthma medication in children who are overweight/obese: justified treatment?

  No n = 64 (18.9) Unlikely n = 44 (13.1) Probable n = 168 (49.7) Confirmed n = 62 (18.3) P-value
Age (years) 8.8 (4.2–16.2) 8.5 (4.1–17.1) 9.5 (4.2–16.9) 7.8 (4.0–17.7) 0.119
Male n (%) 34 (53.1) 27 (61.4) 108 (64.3) 40 (64.5) 0.444
Height (cm) 135.5 (103.3–178.5) 135.2 (104.8–177.1) 139.0 (105.0–196.6) 132.2 (99.5–178.6) 0.226
Height-sds 0.03 (−2.95–1.82) 0.24 (−1.75–2.57) −0.09 (− 2.37–2.65) 0.10 (− 2.23–1.51) 0.433
Weight (kg) 40.9 (19.2–80.6) 35.8 (18.6–85.4) 40.2 (19.1–103.0) 35.9 (15.7–127.0) 0.212
BMI (kg/m2) 21.06 (16.72–30.22) 20.36 (16.65–30.17) 20.84 (16.65–36.35) 19.89 (17.76–39.81) 0.369
BMI-sds 2.09 (1.11–4.23) 1.97 (1.13–4.36) 1.96 (1.11–5.24) 1.93 (1.11–4.19) 0.663
BMI-categories     0.905
 - Overweight 41 (64.1) 29 (65.9) 115 (68.5) 43 (69.4)  
 - Obesity 23 (35.9) 15 (34.1) 53 (31.5) 19 (30.6)  
Spirometry 43 (67.2) 28 (63.6) 131 (78.0) 49 (79.0) 0.101
Reversibility ≥12% 40 (64.5) < 0.001
Clinical diagnosis 168 (100) 56 (90.3) < 0.001
Clinical diagnosis and reversibility ≥12% 34 (54.8) < 0.001
Prescribed asthma medication n (%)    < 0.001
 - β2-agonist 25 (39.1) 37 (84.1) 24 (14.3) 13 (21.0)  
 - ICS 4 (6.3) 20 (11.9) 14 (22.6)  
 - Both 26 (40.6) 116 (69.0) 34 (54.8)  
 - No 9 (14.1) 7 (15.9) 8 (4.8) 1 (1.6)  
  1. Data presented as number (%) or median with range. BMI body mass index, sds standard deviation score, ICS Inhaled Corticosteroids